Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial

Published:2017 Issue:1 Volume:23 Page:141
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Joy Tisha R,McKenzie Charles A,Tirona Rommel G,Summers Kelly,Seney Shannon,Chakrabarti Subrata,Malhotra Neel,Beaton Melanie D

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference42 articles.

1. Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease

2. The global NAFLD epidemic

3. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

4. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women

5. Creutzfeldt W, Frerichs H, Sickinger K. Liver diseases and diabetes mellitus. Prog Liver Dis 1970;3:371-407.

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetes as a risk factor for MASH progression;Diabetes Research and Clinical Practice;2024-11

2. Application and research progress of magnetic resonance proton density fat fraction in metabolic dysfunction-associated steatotic liver disease: a comprehensive review;Abdominal Radiology;2024-07-24

3. Review of current and new drugs for the treatment of metabolic-associated fatty liver disease;Hepatology International;2024-06-08

4. Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction–associated steatotic liver disease;Hepatology;2024-05-08

5. Efficacy of pharmacologic interventions on magnetic resonance imaging biomarkers in patients with nonalcoholic fatty liver disease: systematic review and network meta‐analysis;Journal of Gastroenterology and Hepatology;2024-04-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3